全文获取类型
收费全文 | 43892篇 |
免费 | 6119篇 |
国内免费 | 2172篇 |
专业分类
耳鼻咽喉 | 946篇 |
儿科学 | 1074篇 |
妇产科学 | 618篇 |
基础医学 | 3212篇 |
口腔科学 | 940篇 |
临床医学 | 6538篇 |
内科学 | 7340篇 |
皮肤病学 | 957篇 |
神经病学 | 3075篇 |
特种医学 | 1650篇 |
外国民族医学 | 7篇 |
外科学 | 5767篇 |
综合类 | 6076篇 |
现状与发展 | 8篇 |
一般理论 | 4篇 |
预防医学 | 3751篇 |
眼科学 | 1105篇 |
药学 | 3844篇 |
39篇 | |
中国医学 | 1873篇 |
肿瘤学 | 3359篇 |
出版年
2024年 | 133篇 |
2023年 | 945篇 |
2022年 | 866篇 |
2021年 | 1722篇 |
2020年 | 1945篇 |
2019年 | 1271篇 |
2018年 | 1756篇 |
2017年 | 1662篇 |
2016年 | 1784篇 |
2015年 | 2180篇 |
2014年 | 2909篇 |
2013年 | 3060篇 |
2012年 | 3241篇 |
2011年 | 3339篇 |
2010年 | 2835篇 |
2009年 | 2723篇 |
2008年 | 2430篇 |
2007年 | 2360篇 |
2006年 | 2321篇 |
2005年 | 1861篇 |
2004年 | 1487篇 |
2003年 | 1420篇 |
2002年 | 1126篇 |
2001年 | 951篇 |
2000年 | 694篇 |
1999年 | 630篇 |
1998年 | 538篇 |
1997年 | 540篇 |
1996年 | 500篇 |
1995年 | 432篇 |
1994年 | 314篇 |
1993年 | 204篇 |
1992年 | 221篇 |
1991年 | 186篇 |
1990年 | 116篇 |
1989年 | 172篇 |
1988年 | 126篇 |
1987年 | 109篇 |
1986年 | 112篇 |
1985年 | 110篇 |
1984年 | 100篇 |
1983年 | 77篇 |
1982年 | 85篇 |
1981年 | 63篇 |
1980年 | 60篇 |
1979年 | 38篇 |
1978年 | 51篇 |
1977年 | 48篇 |
1976年 | 34篇 |
1975年 | 51篇 |
排序方式: 共有10000条查询结果,搜索用时 324 毫秒
1.
2.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
3.
4.
5.
Kuo-yi Jade Chang MHealthEc MHM BSc Lisa Lorraine Dillon MSpecEd BPsych Lil Deverell COMS PhD MEd GradDipO&M BEd Mei Ying Boon PhD BOptom FAAO Lisa Keay PhD MPH BOptom 《Clinical & experimental optometry》2020,103(4):434-448
Despite orientation and mobility (O&M) being a significant factor determining quality of life of people with low vision or blindness, there are no gold standard measures or agreement on how to measure O&M performance. In the first part of this systematic review, an inventory of O&M outcome measures used by recent studies to assess the performance of orientation and/or mobility of adults with vision impairment (low vision and blindness) is presented. A wide variety of O&M outcome measures have been implemented in different fields of study, such as epidemiologic research and interventional studies evaluating training, assistive technology, vision rehabilitation and vision restoration. The most frequent aspect of outcome measures is efficiency such as time, distance, speed and percentage of preferred walking speed, followed by obstacle contacts and avoidance, and dis/orientation and veering. Other less commonly used aspects are target identification, safety and social interaction and self-reported outcome measures. Some studies employ sophisticated equipment to capture and analyse O&M performance in a laboratory setting, while others carry out their assessment in real-world indoor or outdoor environments. In the second part of this review, the appropriateness of implementing the identified outcome measures to assess O&M performance in clinical and functional O&M practice is evaluated. Nearly a half of these outcome measures meet all four criteria of face validity (either clinical or functional), responsiveness, reliability and feasibility and have the potential to be implemented in clinical or functional O&M practice. The findings of this review confirm the complicated and dynamic nature of O&M. Multiple measures are required in any evaluation of O&M performance to facilitate holistic assessment of O&M abilities and limitations of each individual. 相似文献
6.
Rupa Narayan MD Traci M. Blonquist MS Ashkan Emadi MD PhD Robert P. Hasserjian MD Meghan Burke BS Christopher Lescinskas BS Donna S. Neuberg ScD Andrew M. Brunner MD Gabriela Hobbs MD Hanno Hock MD PhD Steven L. McAfee MD Yi-Bin Chen MD Eyal Attar MD Timothy A. Graubert MD Christina Bertoli MSN Jenna A. Moran MSN Meghan K. Bergeron MSN Julia E. Foster MSN Aura Y. Ramos BSN Tina T. Som BSN Megan K. Vartanian BSN RN Jennifer L. Story LPN Kristin McGregor MS Molly Macrae BS Tanya Behnan BS Margaret C. Wey PhD Jessica Rae BSN Frederic I. Preffer PhD Patricia Lesho BA Vu H. Duong MD Mason L. Mann BA Karen K. Ballen MD Christine Connolly BS Philip C. Amrein MD Amir T. Fathi MD 《Cancer》2020,126(6):1264-1273
7.
8.
Bo Cai Qiyun Sun Jianhui Qiao Changlin Yu Kaixun Hu Tieqiang Liu Bingxia Li Yajing Huang Yi Wang Hongli Zuo Zheng Dong Yaqing Lei Zhiqing Liu Bo Yao Caixia Li Huisheng Ai Mei Guo 《American journal of cancer research》2020,10(11):3852
Patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) have poor prognosis, and the efficacy of chemotherapy plus tyrosine kinase inhibitors (TKIs) followed by mismatched donor stem cell infusion (microtransplantation, MST) has not been determined. We retrospectively summarized 45 patients including 11 undergoing MST with TKIs, 17 receiving allogeneic transplant and 17 undergoing chemotherapy with TKIs. Improved 4-year overall survival rate was observed in the MST group (91%) compared with either transplant group (31%, P = .005) or chemotherapy group (36%, P = .013). The MST group also had higher 2-year and 4-year leukemia-free survival rates (91% and 72%, respectively) compared with either transplant group (33%, P = .005 and 33%, P = .021, respectively) or chemotherapy group (41%, P = .017 and 31%, P = .023, respectively). 2-year and 4-year cumulative incidences of hematologic relapse were lower in the MST group (9% and 28%, respectively) compared with those in the chemotherapy group (56%, P = .025 and 67%, P = .034, respectively). In patients undergoing MST, donor microchimerism was detected (1.07 × 10-5 to 6.6 × 10-4 copies from 9 to 1499 days) in 7 patients, and donor/patient-derived HLA*0201/2402+WT1+CD8+ T cells were found from 0.05% to 0.67% in 6 patients. MST may provide a favorable treatment for patients with Ph+ ALL. 相似文献
9.
贺雪梅 《临床超声医学杂志》2019,21(10)
借助口服超声助显剂,胃壁及其病变得以清晰显示。本文就经腹超声诊断胃常见疾病和胃排空功能评估方面的一些体会与大家分享,希望经腹胃超声这种无创、实时的检查方式能更普及,使更多患者受益。 相似文献